Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Halog Generic Name & Formulations
Legal Class
Rx
General Description
Halcinonide 0.1%; crm.
Pharmacological Class
Corticosteroid.
See Also
How Supplied
Crm—30g, 60g, 240g
Manufacturer
Mechanism of Action
The precise mechanism of action of halcinonide is unknown, however, it has anti-inflammatory, antipruritic and vasoconstrictive actions.
Halog Indications
Indications
Corticosteroid-responsive dermatoses.
Halog Dosage and Administration
Adults and Children
Apply to affected areas 2–3 times daily. Discontinue when control is achieved. Do not occlude.
Halog Contraindications
Not Applicable
Halog Boxed Warnings
Not Applicable
Halog Warnings/Precautions
Warnings/Precautions
Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Halog Pharmacokinetics
See Literature
Halog Interactions
Not Applicable
Halog Adverse Reactions
Adverse Reactions
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria; HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia, glucosuria.
Halog Clinical Trials
See Literature
Halog Note
Not Applicable
Halog Patient Counseling
See Literature
